PharmaShots Weekly Snapshots (August 22 - 26, 2022)
Published: Aug 26, 2022 | Tags: Aptinyx, NYX-458, Cognitive Impairment, Parkinson’s disease, dementia, Clinical Trial, P-II Study
Published: Aug 26, 2022 | Tags: Athos, Caltech, AI Platform, Inflammatory Bowel Disease, Biotech, proteomics analysis, Research Collaboration
PathAI Extends its Multi-Year Collaboration with BMS to Develop Therapies Using AI
Published: Aug 26, 2022 | Tags: PathAI, BMS, AI, oncology, fibrosis, immunology, Pharma
TG Therapeutics Published P-III (ULTIMATE I & II) Trials Results of Ublituximab for RMS in the NEJM
Published: Aug 26, 2022 | Tags: TG Therapeutics, Ublituximab, Relapsing forms of Multiple Sclerosis, Clinical Trial, NEJM, P-III ULTIMATE I & II Trials
Published: Aug 26, 2022 | Tags: Mycovia, Vivjoa, oteseconazole, Recurrent Vulvovaginal Candidiasis, Clinical Trial, P-III, ultraVIOLET Study
Published: Aug 26, 2022 | Tags: BioMarin, Roctavian, valoctocogene roxaparvovec, Severe Hemophilia A, Regulatory, EC, Conditional Marketing Authorization
Pfizer Reports P-III (RENOIR) Trial Results of RSVpreF Vaccine for Respiratory Syncytial Virus
Published: Aug 25, 2022 | Tags: Pfizer, RSVpreF Vaccine, Respiratory Syncytial Virus, Clinical Trial, P-III RENOIR Trial
Published: Aug 25, 2022 | Tags: AstraZeneca, MSD, Lynparza, Olaparib, BRCA-Mutated, HER2-Negative, High-Risk Early Breast Cancer, Regulatory, MHLW, Approval
Published: Aug 25, 2022 | Tags: Janssen, Tecvayli, teclistamab, Multiple Myeloma, Regulatory, EC, Conditional Marketing Authorization
Published: Aug 25, 2022 | Tags: GNS, Servier, Multiple Myeloma, AI, Pharma, CoMMpass study, Digital Twin
Apellis Reports P-III (DERBY) and (OAKS) Studies Results of Pegcetacoplan for Geographic Atrophy
Published: Aug 25, 2022 | Tags: Apellis, Pegcetacoplan, Geographic Atrophy, age-related macular degeneration, Clinical Trial, P-III DERBY, OAKS Studies
Published: Aug 25, 2022 | Tags: AbbVie, Imbruvica, ibrutinib, Chronic Graft Versus Host Disease, Regulatory, US, FDA, Approval
Published: Aug 24, 2022 | Tags: Iveena, Glaukos, IVMED-80, keratoconus, pediatric myopia, Pharma
Published: Aug 24, 2022 | Tags: Chugai, Polivy, polatuzumab vedotin, Diffuse Large B-cell Lymphoma, Regulatory, MHLW, Approval
Abbott's New Spinal Cord Stimulation Device Receives the US FDA’s Approval for Chronic Pain
Published: Aug 24, 2022 | Tags: Abbott, New Spinal Cord Stimulation Device, Chronic Pain, Regulatory, MedTech, US, FDA, Approval
Published: Aug 24, 2022 | Tags: Oculis, Licaminlimab, OCS-02, OCS-01, OCS-05, Severe Dry Eye Disease, uveitis, Clinical Trial, Clinical Ophthalmology
Published: Aug 24, 2022 | Tags: Sorrento, Abivertinib, Tagrisso, Advanced Non-Small Cell Lung Cancer, Clinical Trial, NDA
Erasca Entered into a Research Collaboration with MD Anderson for RAS/MAPK-Driven Cancers
Published: Aug 24, 2022 | Tags: Erasca, MD Anderson, RAS/MAPK-Driven Cancers, ERAS-007, ERAS-601, ERAS-4, NSCLC & GI malignancies, Pharma
Published: Aug 23, 2022 | Tags: Merck, MK-2060, End-Stage Renal Disease, Regulatory, US, FDA, Fast Track Designation
Teleflex to Acquire Standard Bariatrics for ~$300M
Published: Aug 23, 2022 | Tags: Teleflex, Standard Bariatrics, ~$300M, M&A, Acquire, MiniLap Percutaneous Surgical System, Weck EFx fascial closure portfolio, Titan SGS stapler
Minerva Neurosciences Reports the NDA Submission of Roluperidone to the US FDA for Schizophrenia
Published: Aug 23, 2022 | Tags: Minerva Neurosciences, Roluperidone, Schizophrenia, Regulatory, US, FDA, NDA
Published: Aug 23, 2022 | Tags: Takeda, Qdenga, dengue tetravalent vaccine, Dengue Disease, Regulatory, Indonesia, BPOM, Approval
Chugai Entered into a License Agreement with Noile-Immune Biotech for PRIME CAR-T Technology
Published: Aug 23, 2022 | Tags: Chugai, Noile-Immune Biotech, Pharma, PRIME CAR-T Technology
Alcon Entered into a Definitive Merger Agreement to Acquire Aerie for ~$770M
Published: Aug 23, 2022 | Tags: Alcon, Aerie, Rocklatan, Rhopressa, M&A, ~$770M, ophthalmic pharmaceutical eye drop, Acquire
Published: Aug 22, 2022 | Tags: CSL Vifor, Travere, Sparsentan, IgA Nephropathy, Regulatory, EMA, Acceptance, Conditional Marketing Authorization Application
Insulet’s Omnipod 5 Receives the US FDA’s Clearance for Type 1 Diabetes in Children Aged ≥2 Years
Published: Aug 22, 2022 | Tags: Insulet, Omnipod 5, Type 1 Diabetes, Regulatory, US, FDA, Clearance, Diabetes Care, SmartAdjust technology, Dexcom G6 CGM
Published: Aug 22, 2022 | Tags: SpringWorks Therapeutics, Nirogacestat, Progressing Desmoid Tumors, Clinical Trial, P-III DeFi Trial, ESMO, 2022
Published: Aug 22, 2022 | Tags: Otsuka, Astex, Decitabine, Cedazuridine, Acute Myeloid Leukemia, Regulatory, EMA, MAA
Published: Aug 22, 2022 | Tags: Novavax, COVID-19 Vaccine, Regulatory, US, FDA, Emergency Use Authorization
Published: Aug 22, 2022 | Tags: Gilead, Sunlenca, lenacapavir, HIV Infection, Regulatory, EC, Marketing Authorization
Related Post: PharmaShots Weekly Snapshots (August 15 - 19, 2022)
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.